Evgeniy E. Achkasov

Evgeniy E. Achkasov

Auto-generated profile, based on publicly available information

Evgeniy E. Achkasov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2022 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
DBD. V. Blinov
D. V. Blinov
ASA. G. Solopova
A. G. Solopova
LSL. N. Sandzhieva
L. N. Sandzhieva
EAE. E. Achkasov
E. E. Achkasov
DKD. I. Korabelnikov
D. I. Korabelnikov
SKS. M. Khlopkova
S. M. Khlopkova
Objective: to evaluate the effectiveness of changes in the legal framework that regulates medical rehabilitation (MR) in the Russian Federation.Material and methods. We analyzed the valid Order of the Ministry of Health of the Russian Federation of June 31, 2020 No. 788n “Organization of medical rehabilitation of adults”, which came into legal power on January 1, 2021. It was proposed for public discussion on the introduction of amendments (project of amendments). The changes proposed in the project were compared with the original text of the document. Besides, other legal documents on the organization of medical rehabilitation were analyzed.Results. Order No. 788n regulates the stages of MR, specifies the formation and realization of an individual plan for a multi-disciplinary rehabilitation team based on the evaluation by Rehabilitation Routing Scale. The document includes in-house protocols of profile inpatient and outpatient departments of medical institutions, standards for doctor’s offices equipment, organization of day-time inpatient department, and regulations for MR centers. The project of amendments contains a variant of involvement of the existing additional Groups 1 and 2 medical divisions for the organization of MR, and limitation for the Stage 2 of MR in inpatient settings, which is now possible only for patients who need 24-hour care.Conclusion. The proposed changes have evolutionary character. A lot of issues in the regulatory framework of MR remain unsolved. It is necessary to improve the state policy for MR and perform further clinical studies of its benefits.

25 February 2021 in Asian Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
EBEduard Bezuglov
Eduard Bezuglov
OTOleg Talibov
Oleg Talibov
MBMikhail Butovskiy
Mikhail Butovskiy
VKVladimir Khaitin
Vladimir Khaitin
EAEvgeny Achkasov
Evgeny Achkasov
ALArtemii Lazarev
Artemii Lazarev
Context: Our goal was to review the current literature regarding the ability of substances that have recently been included in the WADA prohibited list (i.e., meldonium, trimetazidine, xenon, and cobalt) or in the monitoring program (i.e., ecdysterone and bemethyl) to enhance performance in athletes or cause adverse effects. Evidence Acquisition: To find out which studies led to the prohibition of the substances mentioned, we searched the PubMed database using keywords including the substances’ or methods’ names, as well as phrases related to various aspects of sports activities and health assessments of athletes. Results: The results obtained during our systematic literature search clearly indicate that there is a lack of scientific evidence supporting the impact of several substances prohibited by WADA (i.e., meldonium, trimetazidine, xenon, and cobalt) on athletic performance or on health in athletes. Conclusions: There is insufficient evidence that the previously mentioned substances have any performance enhancing potential. If left on the list, meldonium may be classified as a “specified substance” because of its wide availability and due to the fact that this drug that can be easily bought over the counter without a prescription.

26 September 2023 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
DBDmitry V. Blinov
Dmitry V. Blinov
ASA. G. Solopova
A. G. Solopova
EAE. E. Achkasov
E. E. Achkasov
EAE. S. Akarachkova
E. S. Akarachkova
OKO. V. Kotova
O. V. Kotova
AVA. Yu. Vlasina
A. Yu. Vlasina
Background. Radical treatment of malignant neoplasms (MNs) of female reproductive system often has serious consequences. Chronic pain syndrome, distress, anxiety and depression, decreased self-esteem, sexual dysfunction and social maladjustment reduce quality of life (QoL) and require psychotherapeutic support.Objective: to create an algorithm for the provision of comprehensive psychotherapeutic support during rehabilitation following the treatment of reproductive system MNs and to evaluate its effect on QoL indicators in women with neuropsychiatric disorders.Material and methods. The algorithm for the provision of comprehensive psychotherapeutic support included clinical interview, cognitive behavioral therapy, visualization, audio therapy, art therapy, group and individual psychotherapy, family psychotherapy, image therapy. The QoL indicators were determined by questionnaires using the Functional Assessment of Cancer Therapy – General (FACT-G) with nosology-specific extensions (subscales of physical well-being, social/family well-being, emotional wellbeing and functional well-being), Hospital Anxiety and Depression Scale (HADS), Kupperman–Uvarova Modified Menopausal Index (MMI). The follow-up period was 1 year after radical surgical treatment of reproductive system MNs in different localizations. The main group received the algorithm for the provision of comprehensive psychotherapeutic support as part of active medical rehabilitation, the comparison group received basic rehabilitation.Results. The study included 47 women with vulvar cancer (VC): active rehabilitation group (VC-1) – 24 patients and basic rehabilitation group (VC-2) – 23 patients; 61 women with endometrial cancer (EC): active rehabilitation group (EC-1) – 29 patients and basic rehabilitation group (EC-2) – 32 patients; 103 women with cervical cancer (CC): active rehabilitation group (CC-1) – 51 patients and basic rehabilitation group (CC-2) – 52 patients; 62 women with stages I–II ovarian cancer (OC) and low malignant potential tumor (LMPT): active rehabilitation group (LMPT-1) – 29 patients and basic rehabilitation group (LMPT-2) – 33 patients. Differences in physical, social/family and functional well-being (FACT-G) were significant from the 6th month and in emotional well-being – by the end of follow-up. Neurovegetative and psycho-emotional disorders, as assessed by Kupperman–Uvarova MMI, showed significant positive dynamics in women who received the algorithm for the provision of comprehensive psychotherapeutic support, in contrast to the comparison group, where these indicators remained without significant dynamics or worsened by the end of the follow-up period. The HADS scores during psychotherapeutic support decreased to normal values at the 6–12th months of follow-up, while those who received the basic rehabilitation continued to have subclinical anxiety and depression.Conclusion. The developed algorithm for psychotherapeutic support as part of active medical rehabilitation of women who underwent radical treatment for reproductive system MNs (VC, EC, CC, OC, and LMPT) has demonstrated its effectiveness, justifuing its implementation in clinical practice.

18 July 2023 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
DBDmitry V. Blinov
Dmitry V. Blinov
ASA. G. Solopova
A. G. Solopova
EAE. E. Achkasov
E. E. Achkasov
AVA. Yu. Vlasina
A. Yu. Vlasina
SAS. A. Akavova
S. A. Akavova
GBG. К. Bykovshchenko
G. К. Bykovshchenko
Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions

28 July 2022 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
ASA. G. Solopova
A. G. Solopova
DBD. V. Blinov
D. V. Blinov
SDS. V. Demyanov
S. V. Demyanov
GDG. V. Demyanov
G. V. Demyanov
EAE. E. Achkasov
E. E. Achkasov
DAD. M. Ampilogova
D. M. Ampilogova
The influence of epigenetic processes on the development of malignant diseases, including gynaecological cancers, is now beyond doubt. DNA methylation, histone modification and post-transcriptional regulation by microRNAs lead to changes in the activity of various genes, contributing to female genital cancers (cervix, endometrium, ovarian). It should be noted that disruptions in gene expression do not only occur in malignant cells, but also in the tumour microenvironment, resulting in disease progression and relapse. However, “epigenetic markers” of carcinogenesis can be useful in the treatment and rehabilitation of patients, making a personalized approach possible.

15 September 2022 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
LSL. N. Sandzhieva
L. N. Sandzhieva
ASA. G. Solopova
A. G. Solopova
DBDmitry V. Blinov
Dmitry V. Blinov
VGV. N. Galkin
V. N. Galkin
EAE. E. Achkasov
E. E. Achkasov
Introduction. Radical surgery for recurrent atypical endometrial hyperplasia (AEH) allows to fully assess pathological changes of the endometrium, a risk of concomitant cancer, and provides insight into proposing a definitive therapy. However, after ovariohysterectomy, young women develop postovariectomy syndrome (POES) and psychosexual disorders profoundly decreasing quality of life (QoL) that requires rehabilitation measures.Aim: to conduct a comparative analysis of QoL in patients with recurrent AEH after hysterectomy with bilateral salpingooophorectomy based on the management tactics in the rehabilitation period.Materials and Methods. In the second part of the prospective randomized comparative study, 58 women diagnosed with recurrent AEH (mean patient age 44.25 ± 3.40 years) underwent a one-year-follow-up, divided into 2 groups according to the management tactics in the rehabilitation period: group 1 – 27 patients with "active" rehabilitation according to the complex rehabilitation and therapeutic protocol proposed by our research group; group 2 – 31 patients with "passive" rehabilitation. To assess the overall QoL, a questionnaire the Functional Assessment of Cancer Therapy for Patients with Endometrial Cancer (FACT-En) was used, analyzing a level of anxiety and depressive disorders with the Hospital Anxiety and Depression Scale (HADS) as well as manifestations of surgical menopause using Kupperman–Uvarova modified menopausal index (MMI) and sexual function – with the Female Sexual Function Index (FSFI) on day 3–7 as well as 3, 6, 12 months after surgical treatment.Results. It was found that inter-group difference was significant in the FACT-En questionnaire observed as early as by 3 months of the study, whereas by 12 months the QoL score in the "active" rehabilitation group increased by 39.36 points based on the FACT-En questionnaire, but only by 17.38 points in the "passive" rehabilitation cohort (p < 0.001). Analyzing Kupperman–Uvarova MMI, the degree of manifested surgical menopause decreased over time in both groups. However, as early as 6 and 12 months after onset, “active” rehabilitation was featured with surgical menopause parameters corresponding to a mild course, whereas “passive” rehabilitation was associated with moderate severity (p < 0.001). Over the entire follow-up period, "active" rehabilitation group was shown to have anxiety parameters decreased from 10.77 ± 2.36 score (subclinical anxiety) to 4.55 ± 1.50 score (normal range), whereas at 6 and 12 months of follow-up the "passive" rehabilitation group was found to have anxiety parameters corresponding to subclinical manifestations. Over time, sexual function improved in both groups, however, the parameters in the "active" vs. "passive" rehabilitation group were significantly higher as early as 3 months after the onset, with similar pattern observed at 6 and 12 months (p < 0.05).Conclusion. The set of rehabilitation measures proposed by us improves psycho-emotional state, corrects POES manifestations, improves sexual function of AEH patients, thereby increasing overall QoL. This is comparable to the results of medical rehabilitation of women after radical treatment with endometrial cancer.